A Survey on Osteoporosis Treatment for Cancer Patients Provided by Designated Cancer Hospitals in Japan

Shun Ishii; Takuya Fukushima; Ryo Kozu; Noriaki Miyata; Jiro Nakano

Return

A Survey on Osteoporosis Treatment for Cancer Patients Provided by Designated Cancer Hospitals in Japan

VernacularTitle:全国がん診療連携拠点病院におけるがん患者の骨粗鬆症診療の実態調査
Author: Shun ISHII ¹ ; Takuya FUKUSHIMA ² ; Ryo KOZU ³ ; Noriaki MIYATA ¹ ; Jiro NAKANO ²
Author Information

1. Department of Rehabilitation, Michinoo-Miyata Orthopaedic Clinic
2. Department of Physical Therapy, Faculty of Rehabilitation, Kansai Medical University
3. Department of Physical Therapy Science, Nagasaki University Graduate School of Biomedical Sciences
Keywords: cancer treatment-induced bone loss; osteoporosis treatment; designated cancer hospitals
From:Palliative Care Research 2024;19(1):59-66
CountryJapan
Language:Japanese
Abstract: Purpose: This study aimed to understand the details of osteoporosis treatment for cancer patients provided by designated cancer hospitals. Methods: This web-based survey included questions on the evaluation and treatment of osteoporosis in cancer patients provided by physicians in the departments of urology, gynecology, hematology, respiratory medicine, respiratory surgery, gastroenterology medicine and gastroenterology surfery. Results: The gynecology, hematology, breast surgery, and urology departments had high rates of bone densitometry and prescriptions of osteoporosis treatment for cancer patients. The most frequently used selection criteria were age, hormone therapy, and steroid use. Conclusion: Osteoporosis treatment and associated selection criteria for cancer patients is different in each department, so we need to educate the evaluation and treatment of cancer treatment-induced bone loss.